Skip to content

Clinical trials

Terminated Phase 2 Immunoglobulin Light-chain Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Phase: Phase 2 Status: Terminated Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20121
20161
20171
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Medical Center3
Fondazione IRCCS Policlinico San Matteo di Pavia2
Prothena Biosciences Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis7
Multiple Myeloma2
Neoplasms, Plasma Cell1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.